InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+2.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Dion Gisele, Director. Insider active across 1 company, notably Cytek Biosciences, Inc.. Cumulatively, 2 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €144k. History available since 22 July 2021. The latest transaction was filed on 22 July 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
5,000 shares@ US$17.0050.0% of flowCommon StockSEC:0001209191-21-048387
Ideal exit: 18 Apr 2022 (T+270)
5,000 shares@ US$17.000.016% mcap50.0% of flowCommon StockSEC:0001209191-21-048387:0
Ideal exit: 18 Apr 2022 (T+270)
2 of 2 declarations
About Dion Gisele
Gisele Dion is a Director at Cytek Biosciences, Inc. She participates in the governance of the company and strategic decision-making. Her experience in the life sciences sector contributes to guiding the direction of Cytek.
